<td id="wa4yw"><option id="wa4yw"></option></td>
  • <td id="wa4yw"><kbd id="wa4yw"></kbd></td><noscript id="wa4yw"><source id="wa4yw"></source></noscript>
    <bdo id="wa4yw"><kbd id="wa4yw"></kbd></bdo><input id="wa4yw"></input>
    <table id="wa4yw"><kbd id="wa4yw"></kbd></table>
  • <td id="wa4yw"><option id="wa4yw"></option></td>
    <option id="wa4yw"></option>
  • <table id="wa4yw"></table>
  • 發布時間:2019-08-03 23:41 原文鏈接: ALKincardiacmyocytes

    Heart formation is cued by a combination of positive and negative signals from surrounding tissues. Inhibitory signals that block heart formation in anterior paraxial mesoderm include Wnt family members expressed in dorsal neural tube and anti-BMPs expressed in the axial tissues (i.e., noggin in the notochord). Wnt signalling pathway, which is essential for setting up the entire body pattern during embryonic development involves glycogen synthase kinase-3 (GSK3). In the absence of Wnt signaling, GSK3 is active and phosphorylates b-catenin resulting in its degradation by ubiquitin-mediated proteolysis. Activation of Wnt signaling inhibits GSK3, thereby preventing phosphorylation of b-catenin, which is then able to move to the nucleus. There it associates with members of the LEF-1/TCF family of transcription factors, which activate the transcription of genes like cyclin-D1, myc, and MMPs. The Wnt signaling pathway is blocked by a family of secreted proteins such as crescent and Dkk-1 sufficient for induction of heart formation in posterior mesoderm. BMP signaling can also be blocked by the BMP antagonists noggin and chordin, which are secreted from the notochord and cooperate with Wnts to prevent cardiogenesis. Receptors for BMPs, members of the transforming growth factor-beta (TGFb) superfamily, are persistently expressed during cardiac development, yet mice lacking type II or type IA BMP receptors die at gastrulation and cannot be used to assess potential later roles in creation of the heart. Activin receptor-like kinase 3 (ALK3) is specifically required at mid-gestation for normal development of the trabeculae, compact myocardium, interventricular septum, and endocardial cushion. Cardiac muscle lacking ALK3 is specifically deficient in expressing TGFb2, an established paracrine mediator of cushion morphogenesis. In humans, congenital heart defects occur with a prevalence of at least 1% in newborns, and are even more common in death before term. Most frequent are defects in septation and the cardiac valves, and few single gene etiologies are known. The invariable defects in myocardium and AV cushion resulting from congenital deletion of ALK3 provide strong support for its assessment as a candidate gene in human congenital heart disease.

    Contributor: Kosi Gramatikoff

    REFERENCES: Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J. (2001) Oct 1;359(Pt 1):1-16. Review. Gaussin V, et al., Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc Natl Acad Sci U S A. (2002) Mar 5;99(5):2878-83. Marvin MJ et al. Inhibition of Wnt activity induces heart formation from posterior mesoderm. Genes Dev. (2001) Feb 1;15(3):316-27. Schneider VA. And Mercola M. Wnt antagonism initiates cardiogenesis in Xenopus laevis. Genes Dev. (2001) Feb 1;15(3):304-15. Tzahor E. and Lassar AB. Wnt signals from the neural tube block ectopic cardiogenesis. Genes Dev. (2001) Feb 1;15(3):255-60.


    相關文章

    “3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段

    萬物蓬勃的7月里迎來了2022年ANTOP獎的申報和評審工作。由島津企業管理(中國)有限公司申報的“3CoinONE全新體驗氣袋進樣器”ANTOP獎進入專家評審階段。獎項名稱:3CoinONE全新體驗......

    青源峰達太赫茲在國際頂級期刊《TrendsinBiotechnology》發文

    青島青源峰達太赫茲科技有限公司研發團隊在國際頂級期刊《TrendsinBiotechnology》(譯名:《生物技術趨勢》)在線發表題為“THzmedicalimaging:frominvitroto......

    firstinclass胃癌一線療法獲FDA突破性療法

    安進宣布,美國FDA授予其在研firstinclass單抗bemarituzumab突破性療法認定,與改良FOLFOX6化療方案(亞葉酸鈣、氟尿嘧啶和奧沙利鉑)聯用,一線治療FGFR2b過表達和HER......

    武田Alunbrig一線治療NSCLC推遲特定患者疾病進展超2年

    日前,武田(Takeda)公司宣布,該公司的下一代ALK抑制劑Alunbrig(brigatinib)在治療ALK陽性非小細胞肺癌(NSCLC)患者的3期臨床試驗中表現出良好的長期療效。在隨訪時間超過......

    金屬所三維伊辛模型精確解研究取得進展

    2007年,中國科學院金屬研究所研究員張志東在英國《哲學雜志》(PhilosophicalMagazine)上發表論文,提出兩個猜想,并在猜想基礎上推定出三維伊辛模型的精確解。被《哲學雜志》審稿人評價......

    羅氏下代測序產品成功準確識別ALK陽性肺癌患者!

    羅氏(Roche)旗下基因泰克近日公布了II/III期臨床研究BFAST(血液首個檢測篩選試驗)單臂隊列的陽性結果。該研究是一項全球性、多中心、開放標簽、多隊列研究,正在評估靶向療法或免疫療法作為單藥......

    CancerRes:循環腫瘤細胞可預測肺癌病人的生存情況

    對于發生ALK重排的非小細胞肺癌患者來說,他們對crizotinib這種藥物的臨床應答持續時間和藥物作用強度都不可預測,幾乎所有病人最終都會產生抵抗。在一項新研究中,來自法國的研究人員評估了存在異常A......

    羅氏肺癌ALK診斷試劑獲得中國批準

    9月12日,羅氏診斷旗下公司Ventana宣布,其基因診斷產品:抗ALK(D5F3)兔單克隆抗體試劑(免疫組織化學法)已經獲得了CFDA的批準,用于輝瑞公司靶向肺癌藥物克唑替尼的伴侶診斷。克唑替尼用于......

    新一代蛋白結構預測技術

    《NatureChemicalBiology》雜志在線版一篇文章介紹,伊利諾斯州立大學JohnA.Gerlt博士率領的研究小組研制出一種新途徑,能夠確定氨基酸序列已知的蛋白的結構和功能。這是首次利用計......

    萃取火焰原子吸收分光光度法測定土壤中的鎘鉈銦銀

    摘要:本實驗用HCl-HNO3-HF-HClO4消解樣品,KI2MIBK萃取火焰原子吸收分光光度法連續測定土壤樣品中的痕量Cd、Tl、In、Ag。方法檢出限:鎘為0.0052μgPg,鉈為0.0156......

    <td id="wa4yw"><option id="wa4yw"></option></td>
  • <td id="wa4yw"><kbd id="wa4yw"></kbd></td><noscript id="wa4yw"><source id="wa4yw"></source></noscript>
    <bdo id="wa4yw"><kbd id="wa4yw"></kbd></bdo><input id="wa4yw"></input>
    <table id="wa4yw"><kbd id="wa4yw"></kbd></table>
  • <td id="wa4yw"><option id="wa4yw"></option></td>
    <option id="wa4yw"></option>
  • <table id="wa4yw"></table>
  • XVideos